June 2024 FDA Recall Bupropion Hydrochloride by Amerisource Health Services Llc
D-0590-2024 - Failed Dissolution Specifications; the product is dissolving faster than the specified limits.

This Class II drug recall was voluntarily initiated by Amerisource Health Services Llc on June 24, 2024 for the product Bupropion Hydrochloride. The FDA reported the reason for recall as failed dissolution specifications; the product is dissolving faster than the specified limits.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0590-2024

Reason for Recall
Failed Dissolution Specifications; the product is dissolving faster than the specified limits.
Initiated
06-24-2024
Reported
07-17-2024
Quantity
2,484 cartons

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amerisource Health Services LLC
Nationwide in the USA
buPROPion Hydrochloride Extended-release Tablets USP (XL) Once-Daily, 150 mg, 100 Tablets (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC: 60687-782-01.

Batch or Lot Expiration Information

Lot# Lot 1017343, Exp. 12/31/2025